Neoplasm Metastasis: all 3,564 studies

Page 15 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.

• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
• Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesCompletedNCT00104650Phase 2Results posted
• A Multiple Myeloma Trial in Patients With Bone MetastasesCompletedNCT00104104Phase 4Results posted
• Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal CancerCompletedNCT00103142Phase 2Results posted
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid LeukemiaCompletedNCT00096122Phase 1/2Results posted
• Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerCompletedNCT00091832Phase 2Results posted
• ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)CompletedNCT00090363Phase 2Results posted
• Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin ChemotherapyCompletedNCT00083616Phase 2Results posted
• Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone MetastasesCompletedNCT00080912Not applicableResults posted
• A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerCompletedNCT00055471Phase 2Results posted
• Vaccine and Chemotherapy for Previously Untreated Metastatic Breast CancerTerminatedNCT00048893Phase 1/2Results posted
• Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionCompletedNCT00045435Phase 2Results posted
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedNCT00042432Phase 2Results posted
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverCompletedNCT00003907Phase 2Results posted
• Stem Cell Transplantation for Metastatic Solid TumorsTerminatedNCT00001880Phase 2Results posted
• Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic MelanomaCompletedNCT00001832Phase 2Results posted
• The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-LymphedemaCompletedNCT07803549Not applicable
• TDXD in Metastatic HER2-Positive Breast CancerCompletedNCT07778407
• Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLCActive, not recruitingNCT07703228Phase 2
• Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and the PVR/CD96 AxisCompletedNCT07650786
• The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung CancerActive, not recruitingNCT07638878
• Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in ChinaCompletedNCT07620951Phase 1
• Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPIActive, not recruitingNCT07457541Phase 1
• Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver CancerCompletedNCT07386639
• A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With RibociclibCompletedNCT07363434
• Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic MalignanciesActive, not recruitingNCT07336238Phase 2
• AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)Active, not recruitingNCT07285694Phase 1/2
• SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular CarcinomaSuspendedNCT07274774Phase 2
• Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT07214961Phase 1
• Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT07162883Phase 3
• A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid TumorsActive, not recruitingNCT07129252Phase 1/2
• Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung CarcinomaCompletedNCT07111104
• Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal MetastasisActive, not recruitingNCT07079462Phase 2
• A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic MelanomaTerminatedNCT07076550Phase 1
• COBRA: Cancer, Older Adults, Balance and Resistance ActivitiesActive, not recruitingNCT07011862Not applicable
• Study of Interactions Between Oncologists and Resuscitators to Optimize Decision Making for Admission of Patients With Metastatic Solid Cancer to the ICU (InterOncoRea)Active, not recruitingNCT06993987
• Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver MetastasesCompletedNCT06980792
• SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal MetastasesActive, not recruitingNCT06940921Phase 1/2
• Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer SubtypesCompletedNCT06936098
• Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung CancerActive, not recruitingNCT06933329Phase 2
• A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal MetastasesActive, not recruitingNCT06926803
• First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled TrialActive, not recruitingNCT06922279Not applicable
• The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate CancerCompletedNCT06915714
• NeoRes Study - Preoperative Chemotherapy in Colorectal Peritoneal Disease Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT06903039
• Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and MetastasisCompletedNCT06884839
• Osteosclerotic Changes on CT Predict Survival in Prostate CancerCompletedNCT06883474
• A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid TumorsTerminatedNCT06877533Phase 1
• The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic CancerActive, not recruitingNCT06873178
• A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminatedNCT06870487Phase 1
• Multicenter Retrospective Study on Patients Treated with Stereotactic Radiosurgery/Radiotherapy for Single Brain Lesions: Evaluation of Treatment Efficacy and Safety, Also Through Radiomic Analysis Methods.Active, not recruitingNCT06869460
• Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT06866548Early Phase 1
• Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian CancerCompletedNCT06853730
• TATE and KN046 in MCRCTerminatedNCT06834399Phase 2
• Comparison of the Effectiveness of Oral Lactase Enzyme and Lactose Free FormulaCompletedNCT06827405Not applicable
• A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerActive, not recruitingNCT06792695Phase 2
• Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node MetastasisCompletedNCT06791174
• Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic MelanomaActive, not recruitingNCT06784648Phase 1/2
• Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic CancerActive, not recruitingNCT06783140Phase 2/3
• Effectiveness of Telephysical Therapy as a Secondary Stroke Prevention Tool in Patients With Minor Stroke.CompletedNCT06780891Not applicable
• Radiomics of Colorectal Liver Metastases: Identification of New Prognostic Biomarkers.CompletedNCT06779734
• The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine TumorCompletedNCT06779708
• Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT TrialActive, not recruitingNCT06745024Phase 3
• Management of Bone MetastasesActive, not recruitingNCT06713941
• A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationTerminatedNCT06682806Phase 2
• IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisSuspendedNCT06677710Phase 1
• Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain MetastasesWithdrawnNCT06676917Phase 2
• High Prevalence of Secondary Arterial Hypertension (HIPRESH) with Prospective Systematic Screening in a Cohort of Consecutive Hypertensive Patients Referring to Regional Specialized CenterCompletedNCT06664255
• Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 TreatmentActive, not recruitingNCT06663787
• Positive Care Effect of the Digital Health Assistant ADELE Blood Pressure for Hypertension PatientsCompletedNCT06663280Not applicable
• A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic CancerCompletedNCT06644170Phase 1
• Comparison of Whole Body DWI to FDG PETActive, not recruitingNCT06630845Not applicable
• A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid TumorsTerminatedNCT06630247Phase 1
• STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWithdrawnNCT06626256Phase 1
• A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsCompletedNCT06619951Phase 1
• A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsActive, not recruitingNCT06607185Phase 1
• Reduction of Arm Volume and Improvement in Lymphedema Via SurgeryCompletedNCT06606145Not applicable
• Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Active, not recruitingNCT06592716
• A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple SclerosisCompletedNCT06588387
• Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesActive, not recruitingNCT06577987Phase 1
• ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast CancerCompletedNCT06570031Phase 1
• A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationTerminatedNCT06560645Phase 1
• LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)TerminatedNCT06558799Phase 2
• Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of TreatmentCompletedNCT06557967
• Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLCActive, not recruitingNCT06557187Not applicable
• Evaluation of the MORENO Score for the RegulationCompletedNCT06555874
• The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open SurgeryCompletedNCT06550700
• Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesSuspendedNCT06549478Phase 1
• A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.TerminatedNCT06546553Phase 1
• A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsTerminatedNCT06540066Phase 1
• Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic CancerCompletedNCT06538623Phase 2
• Virtual Reality for Advanced Cancer PainActive, not recruitingNCT06534580
• A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsActive, not recruitingNCT06533059Phase 1
• Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.Active, not recruitingNCT06506955Phase 2/3
• Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab GovitecanCompletedNCT06504719
• Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainActive, not recruitingNCT06500455Phase 3
• Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After TherapyTerminatedNCT06478862Phase 2
• A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)CompletedNCT06460961Phase 1
• The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PMActive, not recruitingNCT06427252Phase 2
• The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)CompletedNCT06424210
• Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer PatientsWithdrawnNCT06416436Phase 1

← Neoplasm Metastasis overview